PVI
APLT

Pura Vida Investments’s Applied Therapeutics APLT Stock Holding History

Pura Vida Investments’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-101,654
Closed -$77.3K – 82
2022
Q4 		$77.3K Buy
+101,654
New +$80.4K ﹤0.01% 186
2020
Q1 		– Sell
-21,810
Closed -$595K – 96
2019
Q4 		$595K Buy
+21,810
New +$374K 0.05% 98

Other funds holding APLT

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Pura Vida Investments's APLT Position: Q1 2023 in Review

Pura Vida Investments sold out of Applied Therapeutics (APLT) in Q1 2023, closing a stake of 101,654 shares — an estimated $77.3K sold.

Pura Vida Investments first reported a position in APLT in Q4 2019 and held it in 2 quarters. The position peaked at $595K in Q4 2019. 36 funds tracked by Wall St. Rank hold APLT as of Q1 2023.

  • Pura Vida Investments reported no remaining Applied Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Pura Vida Investments sold 101,654 Applied Therapeutics shares in Q1 2023, an estimated $77.3K.
  • Pura Vida Investments first reported a position in Applied Therapeutics in Q4 2019 and held it in 2 quarters.
  • Pura Vida Investments's Applied Therapeutics position peaked at $595K in Q4 2019.
  • 36 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2023.

Based on Pura Vida Investments's 13F filing for Q1 2023, filed 15 May 2023.